Jared Cohen
General CounselDr. Jared Cohen, PhD, JD, is General Counsel of Entrada Therapeutics, Inc. Dr. Cohen was VP and Head of Intellectual Property & Legal Affairs of Entrada Therapeutics, Inc. from April 2020. He joined Entrada in 2020. Prior to Entrada, Dr. Cohen was Vice President of Legal Affairs at Repertoire Immune Medicines (formerly Cogen Therapeutics/Cogen Immune Medicine). Dr. Cohen held a variety of legal roles of increasing responsibility and leadership in the biotechnology and pharmaceutical space, including at Alexion Pharmaceuticals; The Jackson Laboratory; MedImmune/AstraZeneca; Human Genome Sciences; and Finnegan, Henderson, Farabow, Garrett & Dunner. Dr. Cohen holds a BS in biology from Duke University from 1989 to 1993, a PhD in Biochemistry, Molecular and Cell Biology from Cornell University from 1993 to 2001 and a JD from Cornell Law School 2001 to 2004.
Positions
- Company NameEntrada Therapeutics, Inc.Stock CodeTRDAPositionGeneral CounselColleagues
- DDDipal DoshiCEO & Director
- KMKush M. ParmarIndependent Chairman of the Board
- NJNathan J. DowdenPresident & COO
- NSNatarajan SethuramanPresident of Research & Development
- KJKory James WentworthCFO & Treasurer
- MTMary T. ThistleIndustry Leader & Independent Director
- PSPeter S. KimDirector
- BGBernhardt G. ZeiherIndependent Director
